AL-8309A, a novel serotonin 5-HT1A agonist, presented as candidate for AMD therapy May 6, 2009 No Comments
E-10030 plus ranibizumab may cause regression of neovascular degeneration; phase I data disclosed May 6, 2009 No Comments
Fovea reports results from clinical trial of Prednisporin in allergic conjunctivitis May 5, 2009 No Comments
Bayer and Regeneron extend their global development program for VEGF Trap-Eye May 5, 2009 No Comments
Prostanoid agonist PF-04475270 shows promise for glaucoma and ocular hypertension therapy in vivo May 5, 2009 No Comments
GR agonist BOL-303242-X shows efficacy in preclinical studies in CNV and postsurgical scarring May 5, 2009 No Comments
N-Acetylcysteine amide shows preclinical promise for the treatment of retinal degenerative states May 4, 2009 No Comments
The pro-apoptotic peptide TM-601 induces regression of choroidal neovascularization lesions in vivo May 4, 2009 No Comments
RSS